Gyre Therapeutics Inc. (GYRE) — Long-term Investment Intensity
Gyre Therapeutics Inc. (GYRE) has a Long-term Investment Intensity of 12.7% as of September 2025. Long-term investments of $20.32 Million represent 12.7% of total assets of $159.38 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Gyre Therapeutics Inc. net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Gyre Therapeutics Inc. Long-term Investment Intensity (2022–2024)
This chart shows how Gyre Therapeutics Inc.'s Long-term Investment Intensity has evolved across 3 annual periods from 2022 to 2024. As of September 2025, the intensity stands at 12.7%, reflecting long-term investments of $20.32 Million against total assets of $159.38 Million USD. Also explore how large is Gyre Therapeutics Inc.'s balance sheet for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Gyre Therapeutics Inc. (2022–2024)
The table below presents the year-by-year Long-term Investment Intensity for Gyre Therapeutics Inc. from 2022 to 2024, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of Gyre Therapeutics Inc..
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 19.6% | $24.57 Million | $125.41 Million | ▼ -0.5 pp |
| 2023 | 20.1% | $23.43 Million | $116.54 Million | ▲ +11.4 pp |
| 2022 | 8.7% | $7.39 Million | $84.75 Million | — |